$APYP R/M Into SleepX Could Make it a MASSIVE Runner PT: $1+On Nov 11th the company was successfully redomiciled to Nevada leaving just the last administrative steps towards the completion of the merger in December.
twitter.com
FRANCE Patent No. EP11819507.2 renewed in September
twitter.com
UK Patent No. EP2608717 renewed in September
twitter.com
Israeli Patent No. 224854 renewed in August
twitter.com
SleepX also has a portfolio of FIVE patents some of which are used in Fitbit:
www.sleepxclear.com
Intellectual property
The company’s technology is protected by patents in order to provide a strong IP protection, one of the Company's most important assets. Its technology, applications and products, both in the medical and nonmedical fields, are protected by the laws of the United States and other jurisdictions worldwide. The Company's measurement technology utilizes a technique that measures a range of physical parameters as a function of time to a level of accuracy previously unattainable.
The company's patent portfolio includes:
***SYSTEMS AND METHODS FOR SNORING DETECTION AND PREVENTION***
1. HIGH-SENSITIVITY SENSORS FOR SENSING VARIOUS PHYSIOLOGICAL PHENOMENA, PARTICULARLY USEFUL IN ANTI-SNORING APPARATUS AND METHODS.
2. APPARATUS FOR USE IN CONTROLLING SNORING AND SENSOR UNIT PARTICULARLY USEFUL THEREN.
3. APPARATUS AND METHOD FOR DIAGNOSING SLEEP QUALITY
4. ESTIMATION OF SLEEP QUALITY PARAMETERS FROM WHOLE NIGHT AUDIO ANALYSIS
5. APPARATUS AND METHOD FOR DIGNOSING OBSTRUCTIVE SLEEP APNEA
With distinctive innovative sensor technologies and algorithms, the Company is well-positioned to become a market leader in the snoring and obstructive sleep apnea treatment markets.
twitter.com
twitter.com
The company also signed an agreement with NewsDirect's PR Firm for upcoming press release and marketing capabilities once everything has been finalized and completed.
twitter.com
www.sleepxclear.com
